Citation Information :
Khurana A, Suresh S, Lulla C, Bora R, Acharya H, Bora NM, Acharya P. Screening for Birth Defects Strategies for Developing Low Resource Countries. Donald School J Ultrasound Obstet Gynecol 2013; 7 (4):453-461.
Acharya P, Malhotra J, Malhotra N, Suresh S, Khurana A, Lulla C, Acharya H, Bora NM, Bora R, Malhotra K. Screening for Birth Defects Strategies for Developing Low Resource Countries. Donald School J Ultrasound Obstet Gynecol 2013;7(4):453-461.
Ultrasound screening for fetal abnormalities. Report of the RCOG working party. London: Royal College of Obstetricians and Gynaecologists Press; 1997. p 1-58.
Ultrasound for fetal assessment in early pregnancy. Cochrane Review. The Cochrane Library Issue 3. Oxford: John Wiley and Sons, Ltd; 1999.
Maternal serum screening for Down's syndrome: The effects of routine ultrasound scan determination of gestational age and adjustment for maternal weight. Br J Obstet Gynaecol 1992; 99(2):144-149.
6-year experience of prenatal diagnosis in an unselected population in Oxford, UK. Lancet 1998;352(9140):1577-1581.
Ultrasonographic ‘soft markers’ of fetal chromosomal defects. BMJ 1997;314(7085):918.
Canadian guidelines for prenatal diagnosis: genetic indications for prenatal diagnosis. J Soc Obstet Gynaecol 2001 Jun;23(6):525-531.
First trimester Down syndrome screening: free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A. Am J Obstet Gynaecol 1996 Feb;174(2):612-616.
Evaluation of applicability of standard growth curves to Indian women by fetal biometry. J South Asian Federation Obstet Gynecol 2009 Sep-Dec;1(3):55-61.
UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 1998 Aug;352(9125):343-346.
Amniocentesis and its complications. Aust NZJ Obstet JOGC Gynaecol 1992 May;32(2):97-99.
Randomized study of risk of fetal loss related to early amniocentesis versus chorionic villus sampling. Lancet 1997;350(9079):697-703.
MRC working party on the evaluation of chorion villus sampling. Lancet 1994 Jun;337(8756):1491-1499.
WHO/PAHO Consultation on CVS. Prenat Diagn 1999 Feb;19(2):97-99.
Meta-analysis of second-trimester markers for trisomy 21. Ultrasound Obstet Gynecol 201341247-261. Published online 24 January 2013 in Wiley Online Library (wileyonlinelibrary.com).
Royal College of Obstetrics and Gynecology; June 2010.
Combined use of genetic sonography and maternal serum triple marker screening: an effective method for increasing the detection of trisomy 21 in women younger than 35 years. J Ultrasound Med 2001 Jun;20(6):645-654.
Combined second-trimester biochemical and ultrasound screening for Down syndrome. Obstet Gynecol 2002 Dec;100(6):1168-1176.
An 8-center study to evaluate the utility of mid-term genetic sonograms among high-risk pregnancies. J Ultrasound Med 2003 Jan;22(1):33-38.
Effectiveness of the First trimester scan in detection of major structural anomalies. Rhodes, Greece: Presented at the 9th World Congress in Fetal Medicine.
Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev 2003;(3):CD003252.
Challenges in the diagnosis of fetal nonchromosomal abnormalities at 11-13 weeks. Prenat Diagn 2011 Jan;31(1):90-102.
The value of sonography in early pregnancy for the detection of fetal abnormalities in an unselected population Br J Obstet Gynaecol 1999 Sep;106(9):929-936.
The 11-13+6 weeks scan: where do we stand? A 5-year review at Fernandez Hospital. Int J Infertility Fetal Med 2011 Aug;2(2):65-69.
